R94-59852-94397
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 198 / DE
- Registered
- 2022-01-31
- Relationship
- Other
- Guardian
- ZZS-14331-21735
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-11
Dose 1 — Moderna
-
2021-04-06
Dose 2 — Moderna
-
2022-01-31
Registered in v-safe
-
2022-04-07
Survey response — 12 months, dose 2, dependentMedDRA: COVID-19, Dizziness, Menstrual disorder, Mood altered — Feeling: Fair · Be unable to work or attend schoolFree text: Lightheadedness. Changes in her cycle. Definitely changes in her mood and how her hormone birth control medicine works. Had Covid in Feb '22MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Moderna | No |
| 2 | 2021-04-06 | Moderna | No |
Free text
Release 11 — 12 months, dose 2, dependent
Symptoms: Lightheadedness. Changes in her cycle. Definitely changes in her mood and how her hormone birth control medicine works. Had Covid in Feb '22
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Mood altered | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release